These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32859154)

  • 21. Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus.
    Yu PS; Wu PH; Hung WW; Lin MY; Zhen YY; Hung WC; Chang JM; Tsai JR; Chiu YW; Hwang SJ; Tsai YC
    J Clin Endocrinol Metab; 2024 Jul; 109(8):2097-2105. PubMed ID: 38267025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Circulating Trimethylamine
    Flores-Guerrero JL; Osté MCJ; Baraldi PB; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
    PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
    Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
    Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure.
    Organ CL; Otsuka H; Bhushan S; Wang Z; Bradley J; Trivedi R; Polhemus DJ; Tang WH; Wu Y; Hazen SL; Lefer DJ
    Circ Heart Fail; 2016 Jan; 9(1):e002314. PubMed ID: 26699388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study.
    Kanagala P; Squire IB; Jones DJL; Cao TH; Chan DCS; McCann G; Sandhu JK; Quinn PA; McAdam J; Marsh AM; Davies JE; Struck J; Bergmann A; Sabti Z; Twerenbold R; Herrmann T; Kozhuharov N; Mueller C; Ng LL;
    Clin Res Cardiol; 2019 Aug; 108(8):940-949. PubMed ID: 30767059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trimethylamine-N-oxide (TMAO) determined by LC-MS/MS: distribution and correlates in the population-based PopGen cohort.
    Gessner A; di Giuseppe R; Koch M; Fromm MF; Lieb W; Maas R
    Clin Chem Lab Med; 2020 Apr; 58(5):733-740. PubMed ID: 32084001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function.
    Gruppen EG; Garcia E; Connelly MA; Jeyarajah EJ; Otvos JD; Bakker SJL; Dullaart RPF
    Sci Rep; 2017 Oct; 7(1):13781. PubMed ID: 29061990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).
    Wan SH; Stevens SR; Borlaug BA; Anstrom KJ; Deswal A; Felker GM; Givertz MM; Bart BA; Tang WH; Redfield MM; Chen HH
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27512103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke.
    Hou L; Zhang Y; Zheng D; Shi H; Zou C; Zhang H; Lu Z; Du H
    Neurol Res; 2020 Feb; 42(2):153-158. PubMed ID: 31928326
    [No Abstract]   [Full Text] [Related]  

  • 34. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
    Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
    J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury.
    Wu C; Xue F; Lian Y; Zhang J; Wu D; Xie N; Chang W; Chen F; Wang L; Wei W; Yang K; Zhao W; Wu L; Song H; Ma Q; Ji X
    Neurology; 2020 Feb; 94(7):e667-e677. PubMed ID: 31907287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.